← FDA Drug Approvals (Drugs@FDA)

CHOLESTYRAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2021-10-19

Drug application

FDA Application #

ANDA211856

Application type

Abbreviated New Drug Application (Generic)

Brand name

CHOLESTYRAMINE

Generic name

CHOLESTYRAMINE POWDER FOR SUSPENSION

Active ingredients

CHOLESTYRAMINE

Dosage form

POWDER

Route

ORAL

Marketing status

Prescription

Sponsor

ALKEM LABS LTD

Manufacturer

Ascend Laboratories, LLC

First approval

2021-10-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown